JENNIFER MINSHALL: Open Payments
NPI 1487784765 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,386 in 153 payments from 18 companies in 2025. Trend: 2023 $1,961 · 2024 $3,173 · 2025 $2,386
Food & beverage: $2,286Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $384 |
| PFIZER INC. | 24 | $286 |
| LEO Pharma Inc. | 24 | $264 |
| Arcutis Biotherapeutics, Inc. | 25 | $263 |
| Janssen Biotech, Inc. | 8 | $258 |
| Novartis Pharmaceuticals Corporation | 12 | $195 |
| GENZYME CORPORATION | 12 | $193 |
| Regeneron Healthcare Solutions, Inc. | 6 | $174 |
| Amgen Inc. | 3 | $73 |
| Galderma Laboratories, L.P. | 2 | $55 |
Products named: Bimzelx, DUPIXENT, CIBINQO, TREMFYA, COSENTYX, ADBRY, Zoryve, ANZUPGO.
Industry payments across OK — which companies pay providers there.
